NY vs. California vs. Colorado Cannabis: A Real Comparison

New York's adult-use cannabis market is younger than California's and Colorado's, but that doesn't make it lesser — it makes it hungrier. As Silly Nice, a Black-owned, Veteran-owned, family-run brand based in Brooklyn, we launched in March 2024 and are now carried in 150+ licensed adult-use dispensaries across New York State. We've studied every market carefully, because we had to. Here's what we know: New York is not playing catch-up. It's playing its own game.

California legalized adult-use cannabis in 2016. Colorado did it in 2012. New York's Marihuana Regulation and Taxation Act passed in 2021, with licensed dispensaries opening through 2022 and beyond. On paper, we're the new kid. But anyone who's spent time in the Bronx, in Bed-Stuy, in Harlem, in Astoria — anyone who knows New York — understands that late entry doesn't mean slow quality. New Yorkers don't accept second-best. That standard has shaped every product we make.

What Makes a Cannabis Market Mature?

Maturity in a cannabis market isn't just about how long it's been legal. It's about equity policy, consumer sophistication, product diversity, lab testing standards, and the brands that emerge from within the community. By those measures, New York is developing a market identity that California and Colorado simply didn't have at launch — one built with explicit equity frameworks, CAURD licensing for justice-involved entrepreneurs, and a consumer base that has always demanded authenticity. We fit here because this market was built for brands like ours.

California built the cannabis blueprint — no question. The legacy of Prop 215, the medical era, the brands born in Oakland and Los Angeles and Humboldt County — that culture shaped how the entire nation thinks about cannabis. The diversity of strains, the craft genetics scene, the artisanal hash movement — much of what we love about high-quality cannabis was refined or popularized in California. We respect that history deeply.

But California's legal market has also been one of the most troubled in the country. High tax burdens — some of the steepest in the nation — have kept illicit market prices competitive with licensed dispensary prices. Licensing backlogs locked out small operators for years. Many equity applicants who were supposed to benefit from the legal market found themselves priced out, outpaced by multi-state operators, or simply drowning in bureaucracy. The promise of California cannabis hasn't always matched the reality for the communities who built that culture.

Product Quality in California vs. New York

California does produce exceptional cannabis. The genetic library is enormous, and the hash-making tradition — ice water bubble hash, live rosins, solventless concentrates — is world-class. We honor that tradition in our own products. Our Bubble Hash is 1g, solventless, ice-water extracted, at 53.32% THC, 62.86% total cannabinoids, and 6.2% terpene content — priced at $44. That terpene percentage matters. It's the difference between a product that hits hard and one that hits deep, with full flavor and a complete experience. You can see all our lab results at sillynice.com/menu.

New York is rapidly developing its own production identity. Small-batch craft producers — many of them equity licensees — are building a culture of quality that prioritizes transparency, testing, and intentional formulation. That aligns with who we are. We don't scale to sacrifice. We scale to serve.

Colorado was the first state in the country to open adult-use cannabis dispensaries in January 2014. That's a twelve-year head start on New York. The Colorado market has had time to normalize — pricing has dropped, product variety is broad, and the regulatory framework has been refined through years of iteration. For anyone studying how a legal market matures, Colorado is the case study.

Colorado has also dealt with its own equity gaps. The communities most harmed by prohibition — overwhelmingly Black and Latino communities — weren't positioned to benefit from early licensing. The legal market there, like in California, initially rewarded those with access to capital, real estate, and legal infrastructure. Colorado has taken steps to address this in recent years, but the head start went largely to operators who didn't look like us. We see New York's equity framework, however imperfect, as an opportunity to do better from the jump.

Price and Potency: What New York Consumers Are Getting

Colorado's mature market has driven prices down — which sounds like a win, but often comes at the cost of craft quality and small-batch integrity. New York pricing is higher right now, and that reflects real costs: local labor, New York real estate, state tax structures, and the premium of producing honestly. Our Diamond Powder — 1g of ultra-refined THCa crystalline at 86.24% THC and 98.54% total cannabinoids — retails at $50. Our 510 Vape in Pink Stardust, 1g, 81.96% THC, 88.36% total cannabinoids, made with 100% cannabis-derived terpenes, runs $40. These are fair prices for what you're actually getting.

Here's the truth that too many cannabis market comparisons skip over: the states that legalized first didn't lead on equity. They led on access for the already-advantaged. California and Colorado's early years saw the wealth from legal cannabis flow primarily to white-owned, well-capitalized operations, while communities that bore the brunt of drug war enforcement were still tangled in criminal records, denied licenses, and priced out of participation.

New York built its framework with that history in mind. The CAURD program — Conditional Adult-Use Retail Dispensary licenses — was specifically designed for justice-involved applicants, prioritizing those most harmed by prohibition. The Office of Cannabis Management was given an equity mandate. That doesn't mean the system is perfect — far from it. But the intention embedded in New York's structure represents a meaningful departure from what came before. As a Black-owned, Veteran-owned brand, we don't take that lightly. Shane Breen served in the U.S. Army. We both know what it means when systems either include or exclude you — and we built Silly Nice to be part of a market that actually makes room for people like us.

Why We Chose New York, and Why New York Chose Us Back

We didn't launch in 2024 because it was easy. We launched because this is home, and because we believed New York's adult-use consumers deserved a brand that understood them — one that wasn't shipping in product from another coast or staffed by people who'd never walked a Brooklyn block or ridden the 2 train through Crown Heights at midnight. Silly Nice is in this city because we're of this city. And in less than a year, 150+ licensed dispensaries across New York State agreed.

New York is producing some of the most exciting, intentional cannabis products in the country — and that includes ours. Our Frosted Hash Ball, 1g, handmade and artisanal, comes in at 67.34% THC, 78.34% total cannabinoids, and 5.7% terpene content for $50. Our Infused Flower in Papaya Wine — 3.5g at 51.22% THC and 58.63% total cannabinoids, wrapped in live resin and THCa diamonds — retails at $60. These aren't products made to be cheap. They're made to be remembered.

What New York also has that California and Colorado are still chasing is a deeply educated, deeply skeptical consumer base. New Yorkers have been sourcing premium cannabis through legacy networks for decades. They know what quality feels like. They know when they're being sold marketing over substance. That's not a threat to us — it's the best possible environment for a brand that backs every product with independent lab testing and published COAs. We thrive when consumers ask hard questions. Our answers are all at sillynice.com/menu.

The New York Consumer Is Different

From the dispensary in Flatbush to the shop off Atlantic Avenue to the store in Hell's Kitchen or Jackson Heights — New York's cannabis consumers span every borough, every background, every income level. Adults 21 and up who want to unwind after a long shift, celebrate a weekend, or simply enjoy something crafted with real care. This is not a monolith. This is the most diverse cannabis consumer base in the world. And we make products for all of them: concentrates, vapes, infused flower, hash — something for every preference, every ritual, every occasion.

California gave cannabis culture a home. Colorado gave it a legal framework. New York is giving it a conscience. That's not a knock on what came before — it's an acknowledgment that each generation of markets learns from the last. New York entered this space with visibility into what worked, what failed, and what was left undone. And while there's still real work ahead on licensing backlogs, tax policy, and enforcement of illegal operators, the bones of what New York can become are already showing.

As Silly Nice, we're not here to compete with California or Colorado. We're here to represent New York — fully, honestly, with our names on it and our integrity behind every product. Our 2G All-in-One vape in Alaskan Thunder Fuck, 82.46% THC, 84.06% total cannabinoids, USB-C rechargeable at $80, is as premium a vape product as you'll find anywhere in this country. Because New Yorkers deserve that. Because our community — Black, Brown, queer, veteran, working-class, professional, longtime and newly arrived — deserves products made with that level of respect.

We launched in March 2024. We're in 150+ licensed dispensaries across New York State. We're independently lab-tested, small-batch, sustainably packaged, and we publish every Certificate of Analysis publicly. That's the Silly Nice standard. And we're just getting started. New York — the city, the state, the community — you've welcomed us. We don't take that lightly. We take it personally. And we put it into every gram.

Explore more Silly Nice cannabis guides, product deep-dives, and New York dispensary insights below.